A Peek Into The Market Before The Trading Starts - Apple (NASDAQ:AAPL), AMTD IDEA Group (NYSE:AMTD)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Pre-open moversUS stock futures gained in the pre-market, after Apple (NASDAQ: AAPL) reported strong Q3 results yesterday. Futures for the Dow Jones Industrial Average surged 29 points to 15,542.00, while the Standard & Poor's 500 index futures rose 4.60 points to 1,692.90. Futures for the Nasdaq 100 index also gained 26.50 points to 3,052.50.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

A Peek Into Global Markets European markets were higher after upbeat PMI data. The Spanish Ibex Index gained 1.05%, London's FTSE 100 index jumped 0.87%, STOXX Europe 600 Index surged 0.77%, German DAX 30 index rose 0.90% and French CAC 40 Index climbed 1.08%.Asian markets ended mostly lower, with China's Shanghai Composite dropping 0.52%, Japan's Nikkei Stock Average falling 0.32% and Australia's ASX/S&P500 rising 0.34%. India's Sensex tumbled 1.04% and Hong Kong's Heng Seng Index rose 0.24%. The Chinese Flash HSBC Manufacturing PMI declined to 47.7 for the first half of July, versus the reading of 48.2 in June. Broker Recommendation

Analysts at Goldman Sachs upgraded TD Ameritrade Holding (NYSE: AMTD) from “sell” to “neutral.” The target price for TD Ameritrade Holding has been raised from $19 to $27. TD Ameritrade's shares closed at $27.20 yesterday. Breaking news

WellPoint (NYSE: WLP) reported a 24% increase in its second-quarter profit. WellPoint's quarterly profit surged to $800.1 million, or $2.64 per share, from $643.6 million, or $1.94 per share, in the year-earlier quarter. To read the full news, click here.
Maidenform (NYSE: MFB) announced that it has entered into a definitive agreement with HanesBrands (NYSE: HBI) pursuant to which Hanes will acquire all of the outstanding shares of Maidenform for $23.50 per share in cash. To read the full news, click here.
Sarepta Therapeutics (NASDAQ: SRPT) announced its plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the first half of 2014 for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD). To read the full news, click here.
Eli Lilly & Co (NYSE: LLY) reported a 31% rise in its second-quarter earnings and lifted its full-year adjusted earnings forecast. Eli Lilly's quarterly profit surged to $1.21 billion, or $1.11 per share, from $923.6 million, or $0.83 per share, in the year-ago period. To read the full news, click here.